Differential Surface Thrombogenicity of Heparin Coated Bovine Pericardium: Implication in Bioprosthetic Valve Fabrication
Keywords:
bovine pericardium, heparin coating, rough and smooth surface, thrombogenicity, bioprosthetic heart valveAbstract
Sub-acute valve thrombosis limits the full potential of bovine pericardial valves. In this study, the effect of heparin coating and the influence of rough versus smooth pericardial surface on thrombogenicity was evaluated by in vitro methods. This was followed by mitral implantation of bioprosthetic valves with different inflow surfaces in sheep. The presence of conjugated heparin was demonstrated through O-toluidine blue staining and micro Raman spectroscopy. Heparin was estimated by a colorimetric assay for depletion of O-toluidine blue stain following exposure to heparin modified tissue. Functionality of surface bound heparin was demonstrated by platelet adhesion and protein adsorption studies. Difference in surface thrombogenicity of heparin coated rough and smooth surface was evaluated by modified whole blood kinetic clotting time method. Bioprosthetic valves with either rough or smooth surface of heparin coated pericardium forming the inflow surface were implanted in the mitral position of sheep and observed for device thrombosis upto 6 months. Heparin coating rendered the pericardial surface hydrophilic. Adsorbed protein on heparin coated pericardium was less compared to non-coated one. SEM images for platelet adhesion showed absence of platelets on heparin-coated tissue. Surface thrombogenicity evaluation showed difference in thromboresistance for heparin coated and uncoated pericardial surfaces and between heparin coated rough/smooth surfaces. Sheep implanted with valve having heparin coated rough surface
as valve inflow thrombosed in 53 days. In comparison, the valve having heparin coated smooth surface of pericardium forming the valve inflow surface completed the observation period of 6 and 12 months without any valve thrombosis.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Sachin J. Shenoy, S.L. Devika, Vivek V. Pillai, G. Maneesha, P.R. Umashankar, G. Ranjith (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
